Bobby Sandage has over 30 years in pharmaceuticals, serving as CEO of Euclises since 2015. He held leadership roles at several companies and currently serves on multiple boards.
At firms with a similar stage, sector and check size.
One email when Bobby's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckBobby Sandage has over 30 years in pharmaceuticals, serving as CEO of Euclises since 2015. He held leadership roles at several companies and currently serves on multiple boards.
Bobby Sandage invests through Cultivation Capital, which writes checks of $100K to $10M at seed, series a, series b.
Email [email protected], the firm's inbox for founders, and name Bobby in the subject. A warm intro from a founder Cultivation Capital backed works better.
President and Chief Executive Officer at Coronado BioSciences, Inc. (CNDO); President and CEO at Euclises Pharmaceuticals, Inc.; Dow Pharmaceuticals; Merrell Dow; DuPont/American Critical Care; DuPont Merck Pharmaceutical Company; vice president at Covidien (Mallinckrodt) Pharmaceuticals.
Last updated 2026-10-15. Is this you? Ask for a correction.